Department of Rehabilitation, Kita-Fukushima Medical Center, Date, Japan.
Department of Occupational Therapy, School of Health Sciences, Fukushima Medical University, 10-6 Sakaemachi, Fukushima City, Fukushima, Japan.
Breast Cancer. 2023 Jul;30(4):685-688. doi: 10.1007/s12282-023-01450-9. Epub 2023 Mar 14.
The effect of combined risk factors on breast cancer-related lymphedema (BCRL) development has not yet been investigated. This study aimed to determine the combination of risk factors associated with BCRL development in patients who underwent breast cancer resection, including axillary lymph node dissection (ALND).
The participants included 129 women who were diagnosed with early-stage breast cancer and underwent breast cancer resection in this retrospective observational study. We performed a decision tree analysis to detect the combination of risk factors associated with BCRL development using age, body mass index (BMI), surgical side, mastectomy, the extent of ALND, and adjuvant therapy (chemotherapy, hormone therapy, and radiation therapy).
Of the 129 participants, 11 (8.5%) developed BCRL. Postoperative chemotherapy was the optimal variable selected to classify patients who developed BCRL and those who did not. In participants with postoperative chemotherapy, the extent of ALND was selected as the second layer of the decision tree. When ALND was at level 3, BMI was selected as the third layer. We found that BCRL incidence was 44.4% in individuals with a BMI of 23.0 or higher.
The combination of postoperative chemotherapy, level 3 ALND, and BMI of 23.0 or higher may further increase the risk of developing BCRL. The decision tree model will enable the identification of patients with a high risk of developing BCRL, and thus, preventive intervention, careful monitoring, and early treatment will be possible.
联合风险因素对乳腺癌相关淋巴水肿(BCRL)发展的影响尚未得到研究。本研究旨在确定与接受乳腺癌切除术(包括腋窝淋巴结清扫术 [ALND])的患者发生 BCRL 相关的风险因素组合。
在这项回顾性观察研究中,我们纳入了 129 名被诊断患有早期乳腺癌并接受乳腺癌切除术的女性患者。我们使用年龄、体重指数(BMI)、手术侧、乳房切除术、ALND 范围和辅助治疗(化疗、激素治疗和放疗)进行决策树分析,以检测与 BCRL 发展相关的风险因素组合。
在 129 名参与者中,有 11 名(8.5%)发生了 BCRL。术后化疗是分类发生 BCRL 和未发生 BCRL 患者的最佳选择变量。在接受术后化疗的参与者中,ALND 范围被选为决策树的第二层。当 ALND 为 3 级时,BMI 被选为第三层。我们发现,BMI 为 23.0 或更高的个体中,BCRL 发生率为 44.4%。
术后化疗、3 级 ALND 和 BMI 为 23.0 或更高的组合可能进一步增加发生 BCRL 的风险。决策树模型将有助于识别发生 BCRL 风险较高的患者,从而可以进行预防性干预、密切监测和早期治疗。